Mridul Agrawal

Über Mridul

Dr. Agrawal is a physician, scientist, and healthcare entrepreneur dedicated to advancing the care for cancer patients. He is President and co-founder of iuvando Health, a Germany-based, innovative digital health and precision oncology company, that enables patients with cancer to find and access life-saving treatments within clinical trials.

Prior, Dr. Agrawal was a research fellow at Dana-Farber Cancer Institute, Harvard Medical School, and the Broad Institute of MIT and Harvard with a focus on blood cancer. Dr. Agrawal studied medicine at Johns Hopkins University School of Medicine (Baltimore), University of Zurich, and Heidelberg University, where he graduated with a doctorate degree. He also obtained a master’s degree in Health Economics from Heidelberg University.

Dr. Agrawal was a scholar of the German Academic Scholarship Foundation (Studienstiftung des deutschen Volkes). He has been honored with multiple highly prestigious national and international awards both in his role as a physician-scientist and entrepreneur. Dr. Agrawal's impact resonates not only in the accolades he has received but, more significantly, brings tangible improvements to the lives of countless individuals suffering from cancer. Dr. Agrawal's relentless dedication translates into real-world impact, reshaping the landscape of cancer treatment and offering hope to patients around the globe.